C171041Level 4
Carboplatin/Durvalumab/Etoposide Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen containing carboplatin, durvalumab and etoposide that can be used for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and cervical cancer.
**Synonyms:** - Carboplatin and Etoposide (CE) and Durvalumab - Carboplatin-Durvalumab-Etoposide - Carboplatin-Durvalumab-Etoposide Regimen - Carboplatin-Imfinzi-Etoposide - Carboplatin/Durvalumab/Etoposide - Carboplatin/Imfinzi/Etoposide - Durvalumab/Carboplatin/Etoposide
GET
/api/v1/systems/nci_thesaurus/nodes/C171041Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.